RNA-seq analysis in NRG1 and enzalutamide treated 22Pc-EP cell line
UID: 10507
- Description
- Author summary from Gene Expression Omnibus: "Transcriptome prolifing analysis was performed in 22Pc-EP cells to identify differentially regulated genes by enzalutamide and NRG1. 22Pc-EP cells were treated with androgen receptor inhibition (enzalutamide) or a HER3 ligand NRG1 for 48hrs."
The data is from a study on tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer.
-
Access via GEO
Accession #: GSE147976Access via SRARNA Sequence reads for 21 samples
Accession #: SRP255006Access via BioProjectAdditional information about overall initiative.
Accession #: PRJNA622705 - Access Restrictions
-
Free to All
- Access Instructions
- The NCBI Gene Expression Omnibus database provides open access to these files.
- Associated Publications
- Data Type
- Equipment Used
-
Illumina NovaSeq 6000
- Dataset Format(s)
- CSV, XLSX
- Dataset Size
- 1.2 Mb (CSV), 55.0 Mb (XLSX), 23.7 GB (SRA)
Do you have or know of a dataset that should be added to the catalog? Let us know!